Advertisement

American Cancer Society honors John Ruckdeschel with St. George Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Cancer Society recognized John Ruckdeschel, director of the University of Mississippi Medical Center Cancer Institute and professor of medicine in the Division of Hematology and Oncology, for his work and his continuing support of the ACS.

ACS presented the St. George National Award to Ruckdeschel during a ceremony in Jackson on Sept. 20.

Ruckdeschel commended the ACS for its work on the Gertrude C. Ford Hope Lodge in Jackson, currently under construction adjacent to UMMC. The Hope Lodge is scheduled to open in early 2019 and will provide rooms for patients being treated at Jackson-area cancer centers and their family members. Lodging and transportation to treatment are free.

Conceived in 1949 by Charles S. Cameron, former ACS medical and scientific director, the St. George National Award has been presented annually to ACS volunteers nationwide. Nominees must have served as leaders in the community, mission delivery and/or governance in more than one area of focus for a minimum of four continuous years and must represent ACS in a manner that advances the cause and expands community presence. The St. George National Award Task Force reviews all nominations and shares the award winners with the ACS Board of Directors.

Ruckdeschel is a medical oncologist with a focus on thoracic malignancies.

He is a former CEO at the Moffitt Cancer Center in Tampa, leading it to a NCI comprehensive designation. He later served as CEO of the Karmanos Cancer Institute in Detroit and the Nevada Cancer Institute in Las Vegas.

Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 
Advertisement
Advertisement